Key result
Endocardial-only catheter ablation resulted in substantial improvement in ventricular fibrillation recurrences in a patient with Brugada syndrome.
Why the study?
Does endocardial-only catheter ablation reduce ventricular fibrillation recurrences in a patient with Brugada syndrome?
Case Report (n=1)
Does endocardial-only catheter ablation reduce ventricular fibrillation recurrences in a patient with Brugada syndrome?
Endocardial-only catheter ablation may be an effective strategy for reducing ventricular fibrillation recurrences in patients with Brugada syndrome.
May refine substrate ablation in Brugada syndrome; leaves open the predictive value of endocardial potentials.
Brugada syndrome is known to be a life-threatening disease provoking lethal arrhythmias such as ventricular tachycardia/ventricular fibrillation (VF), but non–implantable cardioverter-defibrillator (ICD) treatment strategy remains a topic of discussion.1 Substrate-based catheter ablation of Brugada syndrome has been reported to be effective,2,3 but much is still unknown, for example, the relationship between local abnormal endocardial potentials and ablation results.
No takes yet. Share an insight, caveat, or question.
Hayashi et al. (2016) conducted a case report in Brugada syndrome (n=1). Endocardial-only catheter ablation was evaluated on Ventricular fibrillation recurrences. Endocardial-only catheter ablation resulted in substantial improvement in ventricular fibrillation recurrences in a patient with Brugada syndrome.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: